SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-071431
Filing Date
2007-04-02
Accepted
2007-04-02 08:16:27
Documents
7
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10K d10k.htm 10-K 519938
2 EXHIBIT 23.1 dex231.htm EX-23.1 1462
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8163
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 7996
5 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3440
6 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3464
7 GRAPHIC g31529img1.jpg GRAPHIC 71141
  Complete submission text file 0001193125-07-071431.txt   644166
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15070 | Film No.: 07735687
SIC: 2834 Pharmaceutical Preparations